Carcinoma ex pleomorphic adenoma of the salivary gland: An immunohistochemical study

European Archives of Oto-Rhino-Laryngology

Volumn 264, Issue 7, 2007, Pages 789-795

  Matsubayashi, Saori ^a   Yoshihara, Toshio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Androgen receptor; c erbB 2; Carcinoma ex pleomorphic adenoma; Immunohistochemistry; Salivary gland tumor

Indexed keywords

ANDROGEN RECEPTOR; CYCLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROTEIN P53; SEX HORMONE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SALIVARY GLAND DUCT;

ADENOMA, PLEOMORPHIC; AGED; ANTIBODIES, NEOPLASM; CARCINOMA, DUCTAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249335036     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-007-0256-6     Document Type: Article

References (38)

1. Eneroth CM (1964) Histological and clinical aspects of parotid tumours. Acta Otolaryngol Suppl 191:1-99
2. Eneroth CM, Blanck C, Jakobsson PA (1968) Carcinoma in pleomorphic adenoma of the parotid gland. Acta Otolaryngol 66:477-492
3. Evenson JW, Auclair P, Gnepp DR, El-Naggar AK (2005) World Health Organization classification tumours. Pathology and genetics of head and neck tumours, Chapter 5. IARC, Lyon
4. LiVolsi VA, Perzin KH (1977) Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 39:2209-2230
5. Ellis GL, Auclair PL (1996) Atlas of tumor pathology, third series, fascicle 17. Tumors of the salivary glands. AFIP, Washington DC, pp 155-373
6. Spiro RH, Huvos AG, Strong EW (1977) Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer 39:388-396
7. Tortoledo ME, Luna MA, Batsakis JG (1984) Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol 110:172-176
8. Luna MA (2001) Salivary glands. In: Pilch BZ (ed) Head and neck surgical pathology. Lippincott Williams & Wilkins, Philadelphia, pp 248-349
9. Lewis JE, Olsen KD, Sebo TJ (2001) Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 32:596-604
10. Olsen KD, Lewis JE (2001) Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 23:705-712
11. Allison RT, Best T (1998) p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med 27:434-440
12. Karja VJ, Syrjanen KJ, Kurvinen AK, Syrjanen SM (1997) Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med 26:217-223
13. Li X, Tsuji T, Wen S, Mimura Y, Sasaki K, Shinozaki F (1997) Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression. Cancer 79:2314-2319
14. Yamamoto Y, Kishimoto Y, Wistuba II, Virmani AK, Vuitch F, Gazdar AF, Albores-Saavedra J (1998) DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol Int 48:265-272
15. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E (1995) p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 75:2037-2044
16. Freitas LL, Araujo VC, Martins MT, Chone C, Crespo A, Altemani A (2005) Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation. Int J Surg Pathol 13:337-342
17. Ohtake S, Cheng J, Ida H, Suzuki M, Ohshiro K, Zhang W, Saku T (2002) Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med 31:590-597
18. Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, Takeyama I (1992) Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 102:923-927
19. Kim YT, Kim JW, Lee JW (1998) c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors. Cancer Lett 132:91-97
20. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
21. Hellquist HB, Karlsson MG, Nilsson C (1994) Salivary duct carcinoma-a highly aggressive salivary gland tumour with overexpression of c-erbB-2. J Pathol 172:35-44
22. Etges A, Pinto DS Jr, Kowalski LP, Soares FA, Araujo VC (1995) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol 56:914-918
23. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183-232
24. Yamada K, Iwai K, Okada Y, Mori M (1989) Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours. Virchows Arch A Pathol Anat Histopathol 415:523-531
25. Seifert G, Caselitz J, Hamper K (1987) Receptors and proliferative markers in salivary gland tumors. J Tumor Marker Oncol 2:291-303
26. Shintani S, Funayama T, Yoshihama Y, Alcalde RE, Ootsuki K, Terakado N, Matsumura T (1995) Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res 15:2623-2626
27. Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, Kondo Y, Nagao K (1998) Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer 82:439-447
28. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 77:223-230
29. Jeannon JP, Soames JV, Bell H, Wilson JA (1999) Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci 24:52-54
30. Onitsuka T (1994) Sex hormones in papillary carcinoma of thyroid gland and pleomorphic adenoma of parotid gland. Acta Otolaryngol 114:218-222
31. Miller AS, Hartman GG, Chen SY, Edmonds PR, Brightman SA, Harwick RD (1994) Estrogen receptor assay in polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma of salivary gland origin. An immunohistochemical study. Oral Surg Oral Med Oral Pathol 77:36-40
32. Shick PC, Riordan GP, Foss RD (1995) Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80:440-444
33. Lamey PJ, Leake RE, Cowan SK, Soutar DS, McGregor IA, McGregor FM (1987) Steroid hormone receptors in human salivary gland tumours. J Clin Pathol 40:532-534
34. Nasser SM, Faquin WC, Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801-806
35. Kapadia SB, Barnes L (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11:1033-1038
36. Fan CY, Wang J, Barnes EL (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 24:579-586
37. Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK (2001) Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol 19:865-871
38. Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M (2001) Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer 93:344-350